UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001936
Receipt number R000002356
Scientific Title Safety and efficacy of high-dose leukocytapheresis using a large filter in patients with refractory asthma
Date of disclosure of the study information 2009/05/02
Last modified on 2013/01/31 12:52:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of high-dose leukocytapheresis using a large filter in patients with refractory asthma

Acronym

Safety and efficacy of high-dose leukocytapheresis using a large filter in refractory asthma

Scientific Title

Safety and efficacy of high-dose leukocytapheresis using a large filter in patients with refractory asthma

Scientific Title:Acronym

Safety and efficacy of high-dose leukocytapheresis using a large filter in refractory asthma

Region

Japan


Condition

Condition

Refractory asthma

Classification by specialty

Pneumology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to investigate the efficacy of leukocytapheresis in refractory asthma.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Improvement of the peak flow rate in morning and evening.

Key secondary outcomes

Improvement of the scores in asthma control tests.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

High-dose leukocyapheresis using a large filter is performed once a week and twice totally.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients fulfilled the 2001 criteria for refractory asthma in American Thoracic Society

Key exclusion criteria

Pregnant women.
Patients with severe cardiovascular diseases.
Patients with infective diseases.
Patients with leukocytopenia or anemia.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tamotsu Ishizuka

Organization

Gunma University Graduate Schoo of Medicine

Division name

Department of Medicine and Molecular Science

Zip code


Address

3-39-15 Showa-machi, Maebashi 371-8511, Japan

TEL

027-220-8123

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tamotsu Ishizuka

Organization

Gunma University Graduate School of Medicine

Division name

Department of Medicine and Molecular Science

Zip code


Address

3-39-15 Showa-machi, Maebashi 371-8511, Japan

TEL

027-220-8123

Homepage URL


Email

tamotsui@showa.gunma-u.ac.jp


Sponsor or person

Institute

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

NCT00888472

Org. issuing International ID_1

ClinicalTrials.gov

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 02 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 10 Month 22 Day

Date of IRB


Anticipated trial start date

2008 Year 11 Month 01 Day

Last follow-up date

2012 Year 11 Month 30 Day

Date of closure to data entry

2012 Year 11 Month 30 Day

Date trial data considered complete

2012 Year 11 Month 30 Day

Date analysis concluded

2013 Year 03 Month 30 Day


Other

Other related information



Management information

Registered date

2009 Year 05 Month 02 Day

Last modified on

2013 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002356


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name